Treatment of irritable bowel syndrome: A case-control experience

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 4, 2006, Pages 359-363

  Astegiano, M ^a   Pellicano, R ^a   Terzi, E ^a   Simondi, D ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Dietary integrators; Irritable bowel disease, diagnosis; Irritable bowel disease, therapy

Indexed keywords

CHARCOAL; INULIN; NICOTINAMIDE; PROBIOTIC AGENT; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TRYPTOPHAN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANGELICA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; FOLLOW UP; HUMAN; INTESTINE FUNCTION; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS SPOROGENES; MALE; STREPTOCOCCUS THERMOPHILUS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

ABDOMINAL PAIN; ADULT; ANGELICA; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONSTIPATION; DIARRHEA; FEMALE; HUMANS; INULIN; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NIACINAMIDE; PLANT PREPARATIONS; PROBIOTICS; TIME FACTORS; TREATMENT OUTCOME; TRYPTOPHAN; VITAMIN B COMPLEX;

EID: 33846496158     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. De Giorgio R, Barbara G, Stanghellini V, Cremon C, Salvioli B, De Ponti F et al. Diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;20(Suppl 2):10-22.
2. Pera A, Astegiano M. Diagnostica delle colopatie funzionali. Torino: Edizioni Minerva Medica; 1989.
3. Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet 1997;350:1691-5.
4. American Gastroenterological Association Medical Position Statement: irritable bowel syndrome. Gastroenterology 2002;123:2105-31.
5. Thompson, WG, Longstreth GF, Drossman DA, Heaton KW, Irvine FJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 (Suppl II): II43-II47.
6. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97 (Suppl): S1-S5.
7. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K et al. British Society of Gastroenterology guidelines for the management of the irritable bowel sybdrome. Gut 2000;(SII):ii1-ii19.
8. Agreus L. The epidemiology of functional gastrointestinal disorders. Eur J Surg 1998;(Suppl 583):60-6.
9. Montagnani M. Attualità sui probiotici. Milano: Hippocrates Edizioni medico-scientifiche; 2001.
10. Sanders-Bush E, Mayer S. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Goodman & Gilman's. The pharmacological basis of therapeutics. Ninth edition. New York: McGraw-Hill; 1996.p.249-63.